SCHEMBL8192117

SCHEMBL8192117

COc1cccc(CC2SC(=S)NC2=O)c1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.64
PPARG P37231 4/20 0.52
MPC2 O95563 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2C9 P11712 1/20 0.52
FFAR1 O14842 4/20 0.46
EED O75530 1/20 0.45
CMA1 P23946 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
PTPN1 P18031 2/20 0.43
MAOB P27338 1/20 0.43
PPARA Q07869 1/20 0.42
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
NOD2 Q9HC29 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1247602 0.86 PPARG (0.66) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8173333 0.86 CA2 (0.66) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL13846962 0.83 CA2 (0.58) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL3073739 0.78 CA2 (1.00) CA2PPARGFFAR1MAOBMEN1
SCHEMBL8173780 0.78 CA2 (0.59) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8179494 0.78 CA2 (0.81) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8187284 0.77 CA2 (0.72) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8172766 0.77 SIRT2 (0.68) CA2FFAR1PTPN1MEN1KMT2A
SCHEMBL8179749 0.76 CA2 (0.68) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8198423 0.76 CA2 (0.64) CA2PTPN1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed